Mirae Asset Global Etfs Holdings Ltd. Axsome Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 17,897 shares of AXSM stock, worth $1.78 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,897Holding current value
$1.78 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
308Shares Held
40.3MCall Options Held
429KPut Options Held
615K-
Rtw Investments, LP New York, NY4.63MShares$461 Million6.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$397 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$328 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$235 Million37.71% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.85MShares$184 Million4.89% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.27B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...